Crossmark

Potential impact of NK-cell education on interferon efficacy in the ENDURE trial

Published Online: 2026-03-17

Authors

Fujita, Mai https://orcid.org/0000-0002-6573-0536
Ureshino, Hiroshi https://orcid.org/0000-0002-5034-3699
License Information

Text and Data Mining valid from 2026-03-17

Version of Record valid from 2026-03-17
More Information

Article History

Received: 18 January 2026

Revised: 13 February 2026

Accepted: 10 March 2026

First Online: 17 March 2026

Competing interests

: HU declares honoraria from Novartis. The remaining authors declare no competing financial interests.

Document is current